MEAI: The Non-Hallucinogenic Psychedelic with an ‘Enough Switch’ for Addictions
MEAI seems to function like an “enough switch” in the brain, stopping all further desire for alcohol or cocaine and preventing overuse.
MEAI seems to function like an “enough switch” in the brain, stopping all further desire for alcohol or cocaine and preventing overuse.
A Phase IIa clinical trial of 5-MeO-DMT for the treatment of alcohol use disorder (AUD) has begun this month.
Two psychedelics we will be focusing on which are documented to help treat alcohol use disorder are both classic psychedelics, psilocybin mushrooms and LSD (lysergic acid diethylamide).
A new study indicates that psilocybin-assisted therapy may reduce heavy drinking in patients with alcohol use disorder, with up to half of patients quitting altogether
Clearmind Medicine CEO Adi Zuloff-Shani writes this guest blog about how a new psychoactive molecule called MEAI can treat alcoholism.
End of content
End of content
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.